Literature DB >> 27137137

Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study.

Song-Yi Park1, Lynne R Wilkens1, Laurence N Kolonel2, Brian E Henderson3, Loïc Le Marchand1.   

Abstract

In the Multiethnic Cohort Study, we previously reported that dietary fiber intake was inversely associated with colorectal cancer risk in men only. In women, the inverse relationship was weaker and appeared to be confounded by menopausal hormone therapy (MHT). We re-examined this observation with a greatly increased power. Using Cox proportional hazards models, we analyzed data from 187,674 participants with 4,692 cases identified during a mean follow-up period of 16 years. In multivariable-adjusted models, dietary fiber intake was inversely associated with colorectal cancer risk in both sexes: HR = 0.73, 95% CI: 0.61-0.89 for highest vs. lowest quintile, ptrend  = 0.0020 in men and HR = 0.76, 95% CI: 0.62-0.91, ptrend  = 0.0067 in women. Postmenopausal women who ever used MHT had a 19% lower risk of colorectal cancer (95% CI: 0.74-0.89) compared with MHT never users. In a joint analysis of dietary fiber and MHT, dietary fiber intake was associated with a lower colorectal cancer risk in MHT never users (HR = 0.75, 95% CI: 0.59-0.95, ptrend  = 0.045), but did not appear to further decrease the colorectal cancer risk of MHT ever users (ptrend  = 0.11). Our results support the overall protective roles of dietary fiber and MHT against colorectal cancer and suggest that dietary fiber may not lower risk further among women who ever used MHT. If confirmed, these results would suggest that MHT and dietary fiber may share overlapping mechanisms in protecting against colorectal cancer.
© 2016 UICC.

Entities:  

Keywords:  colorectal cancer; dietary fiber; menopausal hormone therapy; multiethnic population

Mesh:

Year:  2016        PMID: 27137137      PMCID: PMC5503506          DOI: 10.1002/ijc.30172

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  37 in total

1.  Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis.

Authors:  F Grodstein; P A Newcomb; M J Stampfer
Journal:  Am J Med       Date:  1999-05       Impact factor: 4.965

2.  Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies.

Authors:  Yikyung Park; David J Hunter; Donna Spiegelman; Leif Bergkvist; Franco Berrino; Piet A van den Brandt; Julie E Buring; Graham A Colditz; Jo L Freudenheim; Charles S Fuchs; Edward Giovannucci; R Alexandra Goldbohm; Saxon Graham; Lisa Harnack; Anne M Hartman; David R Jacobs; Ikuko Kato; Vittorio Krogh; Michael F Leitzmann; Marjorie L McCullough; Anthony B Miller; Pirjo Pietinen; Thomas E Rohan; Arthur Schatzkin; Walter C Willett; Alicja Wolk; Anne Zeleniuch-Jacquotte; Shumin M Zhang; Stephanie A Smith-Warner
Journal:  JAMA       Date:  2005-12-14       Impact factor: 56.272

3.  Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles.

Authors:  D O Stram; J H Hankin; L R Wilkens; M C Pike; K R Monroe; S Park; B E Henderson; A M Nomura; M E Earle; F S Nagamine; L N Kolonel
Journal:  Am J Epidemiol       Date:  2000-02-15       Impact factor: 4.897

4.  Intake of supplemental and total fiber and risk of colorectal adenoma recurrence in the wheat bran fiber trial.

Authors:  Elizabeth T Jacobs; Anna R Giuliano; Denise J Roe; José M Guillén-Rodríguez; Lisa M Hess; David S Alberts; María Elena Martínez
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-09       Impact factor: 4.254

5.  Use of hormone replacement therapy and the risk of colorectal cancer.

Authors:  Gad Rennert; Hedy S Rennert; Mila Pinchev; Ofer Lavie; Stephen B Gruber
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

6.  Estrogen plus progestin and colorectal cancer incidence and mortality.

Authors:  Michael S Simon; Rowan T Chlebowski; Jean Wactawski-Wende; Karen C Johnson; Andrew Muskovitz; Ikuko Kato; Alicia Young; F Allan Hubbell; Ross L Prentice
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

7.  A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women.

Authors:  Neil Murphy; Howard D Strickler; Frank Z Stanczyk; Xiaonan Xue; Sylvia Wassertheil-Smoller; Thomas E Rohan; Gloria Y F Ho; Garnet L Anderson; John D Potter; Marc J Gunter
Journal:  J Natl Cancer Inst       Date:  2015-08-01       Impact factor: 13.506

8.  Menopausal hormone therapy and risk of colorectal cancer.

Authors:  Jill R Johnson; James V Lacey; Deann Lazovich; Melissa A Geller; Catherine Schairer; Arthur Schatzkin; Andrew Flood
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

9.  Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer.

Authors:  Tess V Clendenen; Karen L Koenig; Roy E Shore; Mortimer Levitz; Alan A Arslan; Anne Zeleniuch-Jacquotte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

10.  Meta-analyses of colorectal cancer risk factors.

Authors:  Constance M Johnson; Caimiao Wei; Joe E Ensor; Derek J Smolenski; Christopher I Amos; Bernard Levin; Donald A Berry
Journal:  Cancer Causes Control       Date:  2013-04-06       Impact factor: 2.506

View more
  4 in total

1.  High-Quality Diets Associate With Reduced Risk of Colorectal Cancer: Analyses of Diet Quality Indexes in the Multiethnic Cohort.

Authors:  Song-Yi Park; Carol J Boushey; Lynne R Wilkens; Christopher A Haiman; Loïc Le Marchand
Journal:  Gastroenterology       Date:  2017-04-17       Impact factor: 22.682

Review 2.  Carbohydrate Nutrition and the Risk of Cancer.

Authors:  Christian A Maino Vieytes; Hania M Taha; Amirah A Burton-Obanla; Katherine G Douglas; Anna E Arthur
Journal:  Curr Nutr Rep       Date:  2019-09

3.  Considering Gender Differences in Portion Sizes to Improve the Accuracy of Nutrient Intakes from A Food Frequency Questionnaire.

Authors:  Minji Kang; Song-Yi Park; Carol J Boushey; Lynne R Wilkens; Loïc Le Marchand; Laurence N Kolonel; Suzanne P Murphy; Hee-Young Paik
Journal:  Nutrients       Date:  2019-06-26       Impact factor: 5.717

4.  Cetuximab versus bevacizumab following prior FOLFOXIRI and bevacizumab in postmenopausal women with advanced KRAS and BRAF wild-type colorectal cancer: a retrospective study.

Authors:  Chunlong Huang; Xiaoyuan Gu; Xianshang Zeng; Baomin Chen; Weiguang Yu; Meiji Chen
Journal:  BMC Cancer       Date:  2021-01-07       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.